These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 25494884)

  • 1. Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development.
    Agarwal P; Bertozzi CR
    Bioconjug Chem; 2015 Feb; 26(2):176-92. PubMed ID: 25494884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering THIOMABs for site-specific conjugation of thiol-reactive linkers.
    Bhakta S; Raab H; Junutula JR
    Methods Mol Biol; 2013; 1045():189-203. PubMed ID: 23913148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current methods for the synthesis of homogeneous antibody-drug conjugates.
    Sochaj AM; Świderska KW; Otlewski J
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):775-84. PubMed ID: 25981886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current ADC Linker Chemistry.
    Jain N; Smith SW; Ghone S; Tomczuk B
    Pharm Res; 2015 Nov; 32(11):3526-40. PubMed ID: 25759187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry.
    VanBrunt MP; Shanebeck K; Caldwell Z; Johnson J; Thompson P; Martin T; Dong H; Li G; Xu H; D'Hooge F; Masterson L; Bariola P; Tiberghien A; Ezeadi E; Williams DG; Hartley JA; Howard PW; Grabstein KH; Bowen MA; Marelli M
    Bioconjug Chem; 2015 Nov; 26(11):2249-60. PubMed ID: 26332743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision Modification of Native Antibodies.
    Wu KL; Yu C; Lee C; Zuo C; Ball ZT; Xiao H
    Bioconjug Chem; 2021 Sep; 32(9):1947-1959. PubMed ID: 34428033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
    Tsuchikama K; An Z
    Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered cysteine antibodies: an improved antibody-drug conjugate platform with a novel mechanism of drug-linker stability.
    Sussman D; Westendorf L; Meyer DW; Leiske CI; Anderson M; Okeley NM; Alley SC; Lyon R; Sanderson RJ; Carter PJ; Benjamin DR
    Protein Eng Des Sel; 2018 Feb; 31(2):47-54. PubMed ID: 29370435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel Chemical Linkers for Next-generation Antibody-drug Conjugates(ADCs)].
    Tsuchikama K
    Yakugaku Zasshi; 2019; 139(2):209-219. PubMed ID: 30713230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody drug conjugates.
    Bakhtiar R
    Biotechnol Lett; 2016 Oct; 38(10):1655-64. PubMed ID: 27334710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
    Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G
    J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of site-specific antibody-drug conjugates using unnatural amino acids.
    Axup JY; Bajjuri KM; Ritland M; Hutchins BM; Kim CH; Kazane SA; Halder R; Forsyth JS; Santidrian AF; Stafin K; Lu Y; Tran H; Seller AJ; Biroc SL; Szydlik A; Pinkstaff JK; Tian F; Sinha SC; Felding-Habermann B; Smider VV; Schultz PG
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16101-6. PubMed ID: 22988081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.
    Singh SK; Luisi DL; Pak RH
    Pharm Res; 2015 Nov; 32(11):3541-71. PubMed ID: 25986175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in the study of site-specific antibody-drug conjugates].
    Sun Y; Huang R; Sun BW
    Yao Xue Xue Bao; 2015 Oct; 50(10):1225-31. PubMed ID: 26837166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the Development of Site-Specific Antibody-Drug Conjugation.
    Zhou Q; Kim J
    Anticancer Agents Med Chem; 2015; 15(7):828-36. PubMed ID: 25731178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry.
    McCombs JR; Owen SC
    AAPS J; 2015 Mar; 17(2):339-51. PubMed ID: 25604608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Status: Site-Specific Antibody Drug Conjugates.
    Schumacher D; Hackenberger CP; Leonhardt H; Helma J
    J Clin Immunol; 2016 May; 36 Suppl 1():100-7. PubMed ID: 27003914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods to Make Homogenous Antibody Drug Conjugates.
    Kline T; Steiner AR; Penta K; Sato AK; Hallam TJ; Yin G
    Pharm Res; 2015 Nov; 32(11):3480-93. PubMed ID: 25511917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the construction of antibody-drug conjugates.
    Chudasama V; Maruani A; Caddick S
    Nat Chem; 2016 Feb; 8(2):114-9. PubMed ID: 26791893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linker technologies for antibody-drug conjugates.
    Nolting B
    Methods Mol Biol; 2013; 1045():71-100. PubMed ID: 23913142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.